Pharma Journalist -

Kite, a Gilead Company announced the U.S. Food and Drug Administration (FDA) has approved commercial production at the company's new CAR T-cell therapy manufacturing facility in…
Read More...

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, and Matrix Clinical Trials, a Matrix Medical Network offering, are…
Read More...

Regeneron Pharmaceuticals, Inc. and Checkmate Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on proprietary technology to harness the power of the immune…
Read More...

Labcorp is collaborating with Xcell Biosciences, Inc. (Xcellbio) to advance critical work that helps clients effectively bring innovative cell and gene therapies to market. Through…
Read More...

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced a collaboration agreement with CtM Biotech (Shanghai) Co., Ltd (hereafter referred to as "CtM Bio") to jointly develop…
Read More...

Ankyra Therapeutics is pleased to announce that it has established a formal Cooperative Research and Development Agreement with the National Cancer Institute (NCI) to pursue basic,…
Read More...

Asahi Kasei Medical concluded an agreement on April 14, 2022 (JST) through a U.S. subsidiary to wholly acquire Bionova Scientific, LLC, a provider of contract process development…
Read More...

Takeda announced that it has received manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (MHLW) for Nuvaxovid® Intramuscular Injection…
Read More...

Ocugen, Inc. a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals and vaccines, and Bharat Biotech (BBIL), a global leader…
Read More...

Halozyme Therapeutics, Inc. and Antares Pharma, Inc. announced that the companies have entered into a definitive agreement pursuant to which Halozyme will acquire Antares for $5.60 per…
Read More...